全文获取类型
收费全文 | 9959篇 |
免费 | 583篇 |
国内免费 | 66篇 |
专业分类
耳鼻咽喉 | 105篇 |
儿科学 | 173篇 |
妇产科学 | 90篇 |
基础医学 | 1382篇 |
口腔科学 | 194篇 |
临床医学 | 809篇 |
内科学 | 2387篇 |
皮肤病学 | 166篇 |
神经病学 | 688篇 |
特种医学 | 470篇 |
外国民族医学 | 1篇 |
外科学 | 1593篇 |
综合类 | 37篇 |
一般理论 | 1篇 |
预防医学 | 219篇 |
眼科学 | 334篇 |
药学 | 660篇 |
中国医学 | 28篇 |
肿瘤学 | 1271篇 |
出版年
2023年 | 49篇 |
2022年 | 93篇 |
2021年 | 186篇 |
2020年 | 113篇 |
2019年 | 153篇 |
2018年 | 216篇 |
2017年 | 162篇 |
2016年 | 184篇 |
2015年 | 216篇 |
2014年 | 294篇 |
2013年 | 321篇 |
2012年 | 498篇 |
2011年 | 574篇 |
2010年 | 315篇 |
2009年 | 271篇 |
2008年 | 527篇 |
2007年 | 467篇 |
2006年 | 480篇 |
2005年 | 465篇 |
2004年 | 495篇 |
2003年 | 439篇 |
2002年 | 488篇 |
2001年 | 321篇 |
2000年 | 293篇 |
1999年 | 269篇 |
1998年 | 145篇 |
1997年 | 112篇 |
1996年 | 107篇 |
1995年 | 100篇 |
1994年 | 92篇 |
1993年 | 68篇 |
1992年 | 189篇 |
1991年 | 170篇 |
1990年 | 189篇 |
1989年 | 179篇 |
1988年 | 171篇 |
1987年 | 120篇 |
1986年 | 109篇 |
1985年 | 140篇 |
1984年 | 96篇 |
1983年 | 74篇 |
1982年 | 43篇 |
1981年 | 39篇 |
1980年 | 42篇 |
1979年 | 75篇 |
1978年 | 50篇 |
1975年 | 37篇 |
1971年 | 37篇 |
1970年 | 41篇 |
1969年 | 40篇 |
排序方式: 共有10000条查询结果,搜索用时 85 毫秒
991.
K. Sakuma K. Watanabe N. Hotta T. Koike K. Ishida K. Katayama H. Akima 《Acta physiologica (Oxford, England)》2009,197(2):151-159
Aim: To determine the adaptive changes in several molecules regulating muscle hypertrophy and atrophy after unloading, we examined whether unilateral lower limb suspension changes the mRNA and protein levels of SRF‐linked (RhoA, RhoGDI, STARS and SRF), myostatin‐linked (myostatin, Smad2, Smad3 and FLRG) and Foxo‐linked (P‐Akt, Foxo1, Foxo3a and Atrogin‐1) mediators. Methods: A single lower limb of each of eight healthy men was suspended for 20 days. Biopsy specimens were obtained from the vastus lateralis muscle pre‐ and post‐suspension. Results: The volume of the vastus lateralis muscle was significantly decreased after unloading. The amount of RhoA, RhoGDI or SRF protein in the muscle was not significantly changed post‐suspension. An RT‐PCR semiquantitative analysis showed increased levels of myostatin mRNA but not Smad2, Smad3 or FLRG mRNA. Unloading did not elicit significant changes in the amount of p‐Smad3 or myostatin protein in the muscle. The amount of p‐Akt protein was markedly reduced in the unloaded muscle. Lower limb suspension did not influence the expression pattern of Foxo1, Foxo3a or Atrogin‐1. Conclusion: Unloading inducing a mild degree of muscle atrophy may decrease p‐Akt and increase myostatin but not SRF‐linked mediators. 相似文献
992.
Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations 总被引:6,自引:5,他引:1
Ian R. A. Mackenzie Manuela Neumann Eileen H. Bigio Nigel J. Cairns Irina Alafuzoff Jillian Kril Gabor G. Kovacs Bernardino Ghetti Glenda Halliday Ida E. Holm Paul G. Ince Wouter Kamphorst Tamas Revesz Annemieke J. M. Rozemuller Samir Kumar-Singh Haruhiko Akiyama Atik Baborie Salvatore Spina Dennis W. Dickson John Q. Trojanowski David M. A. Mann 《Acta neuropathologica》2009,117(1):15-18
993.
Yvonne Davidson Hanan Amin Thomas Kelley Jing Shi Jinzhou Tian Ravindran Kumaran Tammaryn Lashley Andrew J. Lees Daniel DuPlessis David Neary Julie Snowden Haruhiko Akiyama Tetsuaki Arai Masato Hasegawa Rina Bandopadhyay Steve Sikkink Stuart Pickering-Brown David M. A. Mann 《Acta neuropathologica》2009,118(3):359-369
Ubiquitin immunoreactive (UBQ-ir) inclusions were present to variable extents in the inferior olivary nucleus (ION) in 37/48
(77%) patients with frontotemporal lobar degeneration (FTLD), in 10/11 (91%) patients with motor neurone disease (MND), in
5/5 (100%) patients with Alzheimer’s disease (AD), 5/7 (71%) patients with dementia with Lewy bodies, 13/19 (68%) patients
with Parkinson’s disease, 11/11(100%) patients with Progressive Supranuclear Palsy, 2/6 (33%) patients with Multisystem Atrophy,
1/3 (33%) patients with Huntington’s disease and in 14/14 (100%) normal elderly control subjects. In FTLD, UBQ-ir inclusions
were present in 26/32 (81%) patients with FTLD-U, in 10/15 (67%) patients with tauopathy, and in the single patient with Dementia
Lacking Distinctive Histology. In 13 FTLD-U patients, and in a single AD and in 2 MND patients, the UBQ-ir inclusions had
a rounded, spicular or skein-type appearance, and these were also TDP-43 immunoreactive (TDP-43-ir). In all other affected
patients in all diagnostic groups, and in control subjects, the UBQ-ir neuronal cytoplasmic inclusions (NCI) were of a conglomerated
type, resembling a cluster of large granules or globules, but were never TDP-43-ir. In 3 of the 13 FTLD-U patients with spicular
NCI, conglomerated NCI were also present but in separate cells. Double-labelling immunohistochemistry, and confocal microscopy,
for UBQ and TDP-43 confirmed that only the spicular UBQ-ir inclusions in patients with FTLD-U, AD and MND contained TDP-43,
though in these patients there were occasional TDP-43 immunoreactive inclusions that were not UBQ-ir. Nuclear TDP-43 immunoreactivity
was absent in ION in FTLD-U, AD or MND when TDP-43 cytoplasmic inclusions were present, but remained in neurones with UBQ-ir,
TDP-43 negative inclusions. The target protein within the UBQ-ir, TDP-43-negative inclusions remains unknown, but present
studies indicate that this is not tau, neurofilament or internexin proteins. These TDP-43 negative, UBQ-ir inclusions appear
to be more related to ageing than neurodegeneration, and are without apparent diagnostic significance. The pathophysiological
mechanism leading to their formation, and any consequences their presence may have on nerve cell function, remain unknown. 相似文献
994.
Katsuta E Kaneko J Iwata N Aoyagi H Yoshida T Takahata T Hasegawa K Maejima S 《Gan to kagaku ryoho. Cancer & chemotherapy》2011,38(12):2334-2335
A 59-year-old man visited our department with the complaint of an abdominal mass. After detailed examination, he was diagnosed with cT3 (SE) N2M0, cStage III C gastric cancer and underwent a 3 course preoperative S-1/CDDP combination chemotherapy. After tumor down-staging was achieved after the 3 course combination chemotherapy, a surgery was scheduled. The patient underwent distal gastrectomy with D2 lymph node dissection. Histopathological diagnosis was M, type 1, 75 × 35 mm, papillary>moderately-differentiated tubular adenocarcinoma [pT2 (MP), ly3, v0, pN2, Stage IIB]. The patient is now treated with oral S-1 as postoperative adjuvant chemotherapy on an outpatient basis, and there are no signs of recurrence as of 1 year after the surgery. Preoperative chemotherapy appears to be a promising treatment option for gastric cancer with extensive lymph node metastasis. 相似文献
995.
996.
A 66-year-old female had suffered from proptosis in the left eye (OS) and double vision for 1 month due to abnormality of the superior rectus muscle. Visual acuity was noted as 20/20 in both eyes (OU). Eye movement showed limited OS supraduction. Magnetic resonance imaging revealed an indistinct mass in the orbit involving the superior rectus muscle. A biopsy specimen of the orbital tumor led to the histological diagnosis of extranodal marginal zone B-cell lymphoma. Radiotherapy with a total dosage of 30 Gy was administered, which subsequently resolved the tumor. However, the supraduction limitation of ocular movement remained unchanged. Supraduction limitation is due to muscular contraction disorder of the superior rectus muscle, caused by direct lymphoma cell invasion. 相似文献
997.
Tamaki Y Arai T Sugimura H Sasaki T Honda M Muroi Y Matsubara Y Kanno S Ishikawa M Hirasawa N Hiratsuka M 《Drug metabolism and pharmacokinetics》2011,26(5):516-522
Genetic polymorphisms of enzymes involved in the metabolism of carcinogens are suggested to modify an individual's susceptibility to lung cancer. The purpose of this study was to investigate the relationship between lung cancer cases in Japan and variant alleles of cytochrome P450 (CYP) 2A6 (CYP2A6*4), CYP2A13 (CYP2A13*1-*10), CYP4B1 (CYP4B1*1-*7), sulfotransferase 1A1 (SULT1A1*2), glutathione S-transferase M1 (GSTM1 null), and glutathione S-transferase T1 (GSTT1 null). We investigated the distribution of these polymorphisms in 192 lung cancer patients and in 203 age- and sex-matched cancer-free controls. The polymorphisms were analyzed using various techniques including allele-specific PCR, hybridization probe assay, multiplex PCR, denaturing high-performance liquid chromatography (DHPLC), and direct sequencing. We also investigated allele and genotype frequencies and their association with lung cancer risk, demographic factors, and smoking status. The prevalence of the CYP2A6*4/*4 genotype in lung cancer cases was 3.6%, compared with 9.4% in the controls (adjusted OR = 0.36, 95% CI = 0.15-0.88, P = 0.025). In contrast, there was no association between the known CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1 polymorphisms and lung cancer. These data indicate that CYP2A6 deletions may be associated with lung cancer in the Japanese population studied. 相似文献
998.
Fukao M Ishida K Sakamoto T Taguchi M Matsukura H Miyawaki T Hashimoto Y 《Drug metabolism and pharmacokinetics》2011,26(5):538-543
The aim of the present study was to investigate the genetic factors responsible for the interindividual variability in the bioavailability of mizoribine. Thirty healthy Japanese men aged 20-49 years and weighing 53-75 kg participated in the present study and took 150 mg of mizoribine. Urine samples were collected periodically for 12 h after the dose, and the bioavailability of mizoribine was calculated from the estimated total urinary excretion from time zero to infinity. The bioavailability of mizoribine in the 30 subjects ranged from 60.3% to 99.4%. The mean bioavailability of mizoribine in subjects with the concentrative nucleoside transporter 1 (SLC28A1) 565-A/A allele (75.4%) was significantly lower than that in subjects with the SLC28A1 565-G/G allele (90.1%). On the other hand, the bioavailability of mizoribine was not affected by polymorphisms of breast cancer resistance protein (ABCG2) C421A and multidrug resistance-associated protein 4 (ABCC4) G2269A. The findings in the present prospective study suggested that the genetic test for the SLC28A1 G565A polymorphism is promising for predicting the Japanese subjects with lower bioavailability of mizoribine. 相似文献
999.
Tsukumo Y Matsumoto Y Miura H Yano H Manabe H 《Journal of pharmacological sciences》2011,115(1):27-35
We investigated the effects of gabapentin and pregabalin on the itch-associated response in a mouse model of chronic dermatitis induced by the repeated application of 4-ethoxymethylene-2-phenyl-2-oxazolin-5-one (oxazolone). Challenging the mice with oxazolone-induced chronic dermatitis with the oxazolone evoked severe and transient scratching behavior until 1 h after the application of oxazolone. Thereafter, a more mild and continuous scratching behavior was also observed for at least 8 h. Both severe and continuous scratching behaviors were suppressed by systemic injection of gabapentin and pregabalin. This effect of these compounds was correlated with its affinity for the α2δ subunit of voltage-gated Ca2+ channels. Intrathecal injection, but not peripheral treatment, with gabapentin inhibited the scratching behavior in this model. Gabapentin failed to suppress the scratching behavior induced by the intradermal injection of compound 48/80 in normal mice. The expression of the α2δ-1 subunit in dorsal root ganglion (DRG) from mice following repeated application of oxazolone was significantly higher than that from normal mice. These results suggest that gabapentin and pregabalin show an anti-pruritic activity through α2δ-subunit binding, and the up-regulation of the α2δ-1 subunit in DRG may therefore play an important role in its anti-pruritic activity. 相似文献
1000.
Ishida K Kaneda H Uemura O Ushijima K Ohta K Goto Y Satomura K Shimizu M Fujieda M Morooka M Yamada T Yamada M Wada N Takaai M Hashimoto Y 《Drug metabolism and pharmacokinetics》2011,26(1):71-78
The aim of this study was to evaluate limited sampling designs to estimate the maximal concentration (C(max)) and area under the curve (AUC) of mizoribine in pediatric patients with renal disease. We utilized 48 serum mizoribine concentration profiles obtained from the full (6-point) sampling pharmacokinetic test, and estimated 48 individual C(max) and AUC values accurately with Bayesian analysis using the full sampling data. We then developed limited sampling models (LSM) for C(max) and AUC using 1-4 serum mizoribine concentration data points. The C(max) and AUC estimation performance of the Bayesian and LSM analysis was fairly good in the 3-point (2, 3, and 6 hr after the dose) sampling design. In addition, the C(max) estimation performance of the Bayesian and LSM analysis deteriorated only marginally even in the 1-point (3 hr) sampling design. On the other hand, the AUC estimation performance seemed to be inadequate in the 1-point (3 hr) sampling design; however, it improved markedly in the 2-point (3 and 6 hr) sampling design. These findings suggested that the 1-point (3 hr) sampling design is promising for approximate C(max) estimation, but that the 2-point (3 and 6 hr) sampling design is preferable to estimate the AUC of mizoribine. 相似文献